
The Journal of Pediatrics · 2015
Hypoglycemia Guidelines
The Pediatric Endocrine Society has assembled a panel of experts to develop guidelines for managing hypoglycemia in neonates, infants, and children (excluding those with diabetes). These guidelines aim to help physicians recognize and diagnose persistent hypoglycemia disorders, ensuring effective treatment to prevent brain damage in at-risk infants during the critical early months of life.

JIMD Reports · 2021
Method Comparison of Beta-Hydroxybutyrate
This study compared serum and point-of-care (POC) beta-hydroxybutyrate (BHB) levels in 94 healthy children after an overnight fast. The results showed a strong correlation between serum BHB and POC BHB values, with the majority falling within a close range. This suggests that POC BHB measurements are accurate and comparable to serum BHB levels in children following fasting, indicating their utility in medical evaluations and management of hypoglycemic conditions.

Nature Research · 2020
Exome Sequencing Revealed DNA Variants
Unexplained or idiopathic ketotic hypoglycemia (KH) is common in children, but its genetic basis remains unclear. This study analyzed ten preschool-aged KH patients and identified four new candidate genes associated with KH. These genes underlie distinct subtypes of KH and reveal its genetic complexity. Understanding these genetic factors may lead to precision medicine approaches for KH management.

American Journal of Medical Genetics · 2021
PHKA2 Variants
Idiopathic Ketotic Hypoglycemia (IKH) is a diagnosis of exclusion. This multicenter study focused on 12 children from eight families diagnosed or suspected of having IKH. Genetic testing using whole-exome sequencing identified both known and new pathogenic variants in the PHKA2 gene, associated with GSD IXa. Some patients had novel variants, and their enzyme activity was lower than normal.

JIMD Reports · 2021
Eating and Psychosocial Challenges in IKH
This study examines the impact of eating and psychosocial challenges on patients with hepatic GSD and idiopathic ketotic hypoglycemia (IKH). It included 16 patients aged 3 to 24 years and identified Avoidant/Restrictive Food Intake Disorder in five patients, affecting their quality of life. The study also highlights psychosocial issues.

JCEM · 2022
Continuous Glucose Monitoring
This study analyzed continuous glucose monitoring (CGM) metrics in adult Glycogen Storage Disease Type Ia (GSDIa) patients compared to healthy volunteers. CGM sometimes overestimated glucose levels. GSDIa patients showed higher glycemic variability and time above target range but lower time in range. It’s the first such comparison, providing insights into CGM use and interpretation for GSDIa and guiding future research on CGM outcomes.

JIMD Reports · 2016
Extended Release Cornstarch
Glycogen Storage Disease Type I (GSD I) involves severe hypoglycemia during fasting. Extended release cornstarch was studied for its safety and efficacy in GSD I. A significant majority of 106 subjects showed efficacy with extended fasting periods. Long-term data from 44 subjects revealed improved fasting duration and stable metabolic control. This suggests that extended release cornstarch can enhance the quality of life for GSD I patients without compromising metabolic health and may improve safety by eliminating the need for overnight cornstarch doses.

Journal of Pediatric Endocrinology · 2023
Fasting Ketone Levels Vary by Age
This study measured fasting serum beta-hydroxybutyrate (BHB) concentrations in healthy children after an overnight fast. Results showed that children ≤3 years old had significantly higher BHB concentrations compared to older children. Fasting BHB levels >1.0 mmol/L were rare, suggesting a potential threshold for pathological ketotic hypoglycemia. Establishing normative ranges is crucial for distinguishing physiological from pathological ketosis in children.